33 related articles for article (PubMed ID: 28681104)
1. Evaluation of 2 breast cancer risk models in a benign breast disease cohort.
Frank RD; Winham SJ; Vierkant RA; Frost MH; Radisky DC; Ghosh K; Brandt KR; Sherman ME; Visscher DW; Hartmann LC; Degnim AC; Vachon CM
Cancer; 2018 Aug; 124(16):3319-3328. PubMed ID: 29932456
[TBL] [Abstract][Full Text] [Related]
2. Benign breast disease and breast cancer risk in African women: a case-control study.
Omoleye OJ; Freeman JQ; Oluwasanu M; Adeniji-Sofoluwe A; Woodard AE; Aribisala BS; Adejumo PO; Ntekim A; Makumbi T; Ndom P; Ajayi IO; Olopade OI; Huo D
Cancer Causes Control; 2024 May; 35(5):787-798. PubMed ID: 38177455
[TBL] [Abstract][Full Text] [Related]
3. Benign breast disease and breast cancer risk in African women: A case-control study.
Omoleye OJ; Freeman JQ; Oluwasanu M; Adeniji-Sofoluwe A; Woodard AE; Aribisala BS; Adejumo PO; Ntekim A; Makumbi T; Ndom P; Ajayi IO; Olopade OI; Huo D
Res Sq; 2023 Sep; ():. PubMed ID: 37693385
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of thyroid nodules in breast cancer women with different clinicopathological characteristics: a cross-sectional study.
Ma CY; Liang XY; Ran L; Hu L; Zeng FL; She RL; Feng JH; Jiang ZY; Li ZX; Qu XQ; Peng BQ; Wu KN; Kong LQ
Clin Transl Oncol; 2024 Apr; ():. PubMed ID: 38609703
[TBL] [Abstract][Full Text] [Related]
5. The crosstalk between benign thyroid disease and breast cancer: A single center study.
Zheng Y; Tang H; Wu J; Guan D; Mo Q; Zheng Q
Medicine (Baltimore); 2024 Mar; 103(10):e37298. PubMed ID: 38457535
[TBL] [Abstract][Full Text] [Related]
6. Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions.
Lu M; Liu H; Zheng B; Sun S; Chen C
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291901
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Thyroid Cancer.
Kitahara CM; Schneider AB
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1284-1297. PubMed ID: 35775227
[No Abstract] [Full Text] [Related]
8. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis.
Dyrstad SW; Yan Y; Fowler AM; Colditz GA
Breast Cancer Res Treat; 2015 Feb; 149(3):569-75. PubMed ID: 25636589
[TBL] [Abstract][Full Text] [Related]
9. [Oral contraception and benign breast diseases: point of view of the epidemiologist].
Lê MG; Charreau I
Bull Cancer; 1991; 78(4):357-63. PubMed ID: 1859903
[TBL] [Abstract][Full Text] [Related]
10. Benign breast disease and risk of thyroid cancer.
Luo J; Hendryx M; Nassir R; Cheng TD; Lane D; Margolis KL
Cancer Causes Control; 2017 Sep; 28(9):913-920. PubMed ID: 28681104
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of endometriosis and risk of benign breast disease.
Farland LV; Tamimi RM; Eliassen AH; Spiegelman D; Collins LC; Schnitt SJ; Missmer SA
Breast Cancer Res Treat; 2016 Oct; 159(3):545-52. PubMed ID: 27604359
[TBL] [Abstract][Full Text] [Related]
12. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
Tice JA; Miglioretti DL; Li CS; Vachon CM; Gard CC; Kerlikowske K
J Clin Oncol; 2015 Oct; 33(28):3137-43. PubMed ID: 26282663
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.
Figueroa JD; Gierach GL; Duggan MA; Fan S; Pfeiffer RM; Wang Y; Falk RT; Loudig O; Abubakar M; Ginsberg M; Kimes TM; Richert-Boe K; Glass AG; Rohan TE
Breast Cancer Res; 2021 Mar; 23(1):34. PubMed ID: 33736682
[TBL] [Abstract][Full Text] [Related]
14. Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.
Arthur R; Wang Y; Ye K; Glass AG; Ginsberg M; Loudig O; Rohan T
Breast Cancer Res Treat; 2017 Oct; 165(3):623-631. PubMed ID: 28643020
[TBL] [Abstract][Full Text] [Related]
15. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
Cui Y; Page DL; Lane DS; Rohan TE
Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
